Yoshiaki Furuyama

I previously worked in the field of private healthcare services as COO of Jiyugaoka Clinic.

Rooted in plastic and cosmetic surgery, Jiyugaoka Clinic brings together specialists dedicated to addressing the unique aesthetic concerns of each patient. Since it was founded by our current Chairman, Nobutaka Furuyama, we have pursued medical care not only for outward beauty but also to enable individuals to live more positively and true to themselves.

Through my interactions with many patients in that clinical setting, I developed a strong conviction about the importance of medical care that supports health and vitality from within the body, rather than relying solely on appearance-focused interventions.

"To what extent can medicine contribute to enabling people to continue living healthily and true to themselves as they age?"

This very question became the genesis of Tokyo Relife Clinic. Aging is a natural process for everyone. On the other hand, challenges such as declining physical function, chronic fatigue, general malaise, loss of vitality, and anxiety about the future should not be dismissed as mere aging; I believe they are crucial themes that must be addressed medically.

In this context, I encountered longevity medicine—healthcare aimed at extending human healthspan. By scientifically understanding aging, quantifying physiological status, and providing tailored interventions for each individual, we make it possible to extend the healthspan. I felt immense potential in this approach. Furthermore, the essential keys to achieving this are regenerative medicine and cell-based medicine.

When we conceptualised Tokyo Relife Clinic, there were already many pioneers in the field of regenerative medicine. On the other hand, regenerative medicine within the private healthcare sector still had many areas that were under development in terms of accumulating clinical data and objectively evaluating therapeutic efficacy.

"Are the patients' conditions truly improving?"

"For which individuals is a specific treatment most suitable?"

"What kind of changes are occurring inside the body before and after treatment?"

Facing such questions based on scientific data is indispensable for the future of regenerative medicine and longevity medicine. To achieve this, Tokyo Relife Clinic set out to construct a synergistic medical model that seamlessly unites academia, clinical practice, and Cell Processing Centers (CPCs). We safely validate cutting-edge discoveries generated through research in clinical settings and return the resulting data back to research. I believe that this very cycle is necessary to develop regenerative medicine into a more reliable form of healthcare. Since 2023, with the cooperation of Professor Keisuke Goda of the University of Tokyo, we have commenced initiatives regarding cellular senescence control. Then, on January 23, 2025, we opened Tokyo Relife Clinic.

Since our opening, what we have valued is not merely providing advanced treatments. It is to verify the safety and efficacy of each treatment, accumulate clinical data, and construct evidence that contributes to the future of regenerative medicine and longevity medicine. Currently, Tokyo Relife Clinic combines regenerative medicine, cellular senescence control, exosomes, stem cell-related technologies, and various tests that visualise aging and health conditions, to aim for the establishment of personalised medicine healthcare that provides the most suitable medical care for each individual patient.

Furthermore, our in-house laboratory continuously verifies the advanced technologies emerging from academia on a daily basis. In 2025, together with the Goda Lab at the University of Tokyo, we commenced joint research aimed at taking on the challenge of XPRIZE, a global competition. This milestone is clear evidence that the rigorous scientific approach we have pursued is now advancing to the next level.

The mission of Tokyo Relife Clinic is to promptly and safely bridge the cutting-edge knowledge generated in laboratories to clinical settings. Through evidence-based regenerative medicine and longevity medicine, we aim to contribute to extending people's human healthspan, improving their quality of life, and enabling a future where they can continue to live true to themselves.

Toward a society that sees aging not as decline or resignation, but as possibility.

Believing in the potential of regenerative medicine and longevity medicine, Tokyo Relife Clinic will continue to earnestly take on challenges step by step, aiming for a new form of healthcare that connects clinical practice, research, and social implementation.